L089-0353 Screening compound: 4-tert-butyl-N-[(E)-N'-(5-chloro-2-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

L089-0353 Screening compound: 4-tert-butyl-N-[(E)-N'-(5-chloro-2-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide
L089-0353 Screening compound: 4-tert-butyl-N-[(E)-N'-(5-chloro-2-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L089-0353
4-tert-butyl-N-[(E)-N'-(5-chloro-2-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L089-0353

Molecular Formula

C25H33ClN4O3 (C25 H33 ClN4 O3)

Compound Name

4-tert-butyl-N-[(E)-N'-(5-chloro-2-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

IUPAC name

4-tert-butyl-N-[(E)-N'-(5-chloro-2-methoxyphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

SMILES

CC(C)(C)c(cc1)ccc1C(N/C(/NCCN1CCOCC1)=N/c(cc(cc1)Cl)c1OC)=O

InChI

InChI=1S/C25H33ClN4O3/c1-25(2,3)19-7-5-18(6-8-19)23(31)29-24(27-11-12-30-13-15-33-16-14-30)28-21-17-20(26)9-10-22(21)32-4/h5-10,17H,11-16H2,1-4H3,(H2,27,28,29,31)

InChI Key

FHPQJANMEJRQCQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27231366

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.01

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.482

Distribution Coefficient, logD

3.338

Water Solubility, LogSw

-4.52

Polar Surface Area

60.516

Acid Dissociation Constant (pKa)

10.31

Base Dissociation Constant (pKb)

8.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

L089-0353 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L089-0353 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L089-0353?
Check Price and Availability of L089-0353, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L089-0353 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L089-0353
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L089-0353
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L089-0353 available by request